Navigation Links
Anastrozole Is A More Effective Cancer Drug

The NHS of the UK has come under increased pressure from charities for making it possible to increase access to a new breast cancer drug which is better than tamoxifen//. Women suffering from the early stages of the disease are treated with tamoxifen. If the women who were treated with tamoxifen for two years were to switch over to anastrozole, one of the new drugs, they are more likely to be alive after a period of two and a half years, according to the research.

In the case of the patients who had switched drugs, the deaths had gone down by 29%. The study was conducted on over 4,000 women across Italy, Germany, and Australia. The deaths among the 2,009 women who changed over to anastrozole was 66, while in the case of tamoxifen, it was 90.

AstraZeneca is marketing anastrozole as Arimidex, and this has received the support of the NHS in Scotland. Tamoxifen administered over 5 years after initial surgery brought down the recurrence of breast cancer by 50%, and administering anastrozole reduces it by a further 26%.

In the UK alone as many as 32,000 postmenopausal women are diagnosed with breast cancer every year, and as three quarters of the tumors are due to sex hormone oestrogen, they are ideal for the new treatment. Arimidex belongs to the aromotase inhibitors class of drugs which prevents the further development of oestrogen.

The treatment costs £68 per month, and it is very much more expensive than tamoxifen. Aromatase inhibitors prevent estrogen and also do not increase the possibilities of endometrial cancer and blood clots. The three brands of this medicine are Novartis Pharmaceuticals’ Femara, Pfizer Inc.’s Aromasin and AstraZeneca PLC’s Arimidex
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... , ... May 03, 2016 , ... Ogawa World USA ... its user friendly Samsung tablet and exclusive Smart Application. The Smart 3D combines the ... each massage with a customized user profile and specialized massage program, each user has ...
(Date:5/3/2016)... NY (PRWEB) , ... May 03, 2016 , ... ... for the healthcare industry, announced today that Legacy Health is expanding its use ... Works platform), after a highly successful initial proof of concept. The Portland, Oregon ...
(Date:5/3/2016)... VA (PRWEB) , ... May 03, 2016 , ... ... provider of innovative information technology (IT) solutions and digital consulting services to the ... Information Technology Services (EITS) Indefinite Delivery / Indefinite Quantity (ID/IQ) contract in support ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Huntington Beach ... type of surgical procedure that can be used to diagnose and treat joint problems. ... be inserted. These instruments include a special lighting system and lens that illuminate and ...
(Date:5/3/2016)... ... ... Branches, Inc. is proud to have been selected as a Macy’s grant ... Miami. Macy’s is a wonderful community partner and has helped to support Branches’ student ... and academic support to elementary students 5 days a week. Summer Shade, a 7 ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... FRANCISCO , May 2, 2016 ... expected to reach USD 11.1 billion by 2024, ... View Research, Inc. Major drivers of the sonography ... therapeutic areas and government recommendations for periodic ultrasound ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... 2016 ReportsnReports.com adds "Pulmonary ... research report that provides an overview of the ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Pulmonary ...
(Date:4/29/2016)... , April 29, 2016 ... Directeur Financier Sanofi, leader ... publie ses résultats pour le premier ... Groupe, Jérôme Contamine, commente les résultats ... les perspectives pour le reste de ...
Breaking Medicine Technology: